Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iain Kilty

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Current Drug Targets|June 22, 2006
Antioxidant therapeutic targets in COPDIrfan Rahman, Iain Kilty
Future Medicinal Chemistry|January 14, 2015
TAK1 selective inhibition: state of the art and future opportunitiesIain Kilty, Lyn H Jones
Respiratory Research|November 13, 2007
The role of IFN-gamma in regulation of IFN-gamma-inducible protein 10 (IP-10) expression in lung epithelial cell and peripheral blood mononuclear cell co-culturesMaria Torvinen, Hinnah Campwala, Iain Kilty
International Immunopharmacology|May 8, 2012
LPS challenge in healthy subjects: an investigation of neutrophil chemotaxis mechanisms involving CXCR1 and CXCR2Raminder Aul, Sheena Patel, Susan Summerhill, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 16, 2013
Mitochondrial superoxide generation enhances P2X7R-mediated loss of cell surface CD62L on naive human CD4+ T lymphocytesJohn G Foster, Edward Carter, Iain Kilty, et al.
Arthritis Research & Therapy|December 7, 2019
Safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06650833, a selective interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, in single and multiple ascending dose randomized phase 1 studies in healthy subjectsSpencer I Danto, Negin Shojaee, Ravi Shankar P Singh, et al.
BMC Medical Genetics|November 4, 2010
Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control studyAndras Penyige, Szilard Poliska, Eszter Csanky, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 14, 2023
Quantifying Cell Death Induced by the NLRC4 InflammasomeStefan Emming, Mercedes M Monteleone, Hiroto Kambara, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 14, 2006
Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophagesSe-Ran Yang, Asiya S Chida, Mark R Bauter, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 1, 2004
Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-kappaB activation and proinflammatory cytokine release in alveolar epithelial cellsFiona M Moodie, John A Marwick, Charlotte S Anderson, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Current Drug Targets|June 22, 2006
Antioxidant therapeutic targets in COPDIrfan Rahman, Iain Kilty
Future Medicinal Chemistry|January 14, 2015
TAK1 selective inhibition: state of the art and future opportunitiesIain Kilty, Lyn H Jones
Respiratory Research|November 13, 2007
The role of IFN-gamma in regulation of IFN-gamma-inducible protein 10 (IP-10) expression in lung epithelial cell and peripheral blood mononuclear cell co-culturesMaria Torvinen, Hinnah Campwala, Iain Kilty
International Immunopharmacology|May 8, 2012
LPS challenge in healthy subjects: an investigation of neutrophil chemotaxis mechanisms involving CXCR1 and CXCR2Raminder Aul, Sheena Patel, Susan Summerhill, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 16, 2013
Mitochondrial superoxide generation enhances P2X7R-mediated loss of cell surface CD62L on naive human CD4+ T lymphocytesJohn G Foster, Edward Carter, Iain Kilty, et al.
Arthritis Research & Therapy|December 7, 2019
Safety, tolerability, pharmacokinetics, and pharmacodynamics of PF-06650833, a selective interleukin-1 receptor-associated kinase 4 (IRAK4) inhibitor, in single and multiple ascending dose randomized phase 1 studies in healthy subjectsSpencer I Danto, Negin Shojaee, Ravi Shankar P Singh, et al.
BMC Medical Genetics|November 4, 2010
Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control studyAndras Penyige, Szilard Poliska, Eszter Csanky, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 14, 2023
Quantifying Cell Death Induced by the NLRC4 InflammasomeStefan Emming, Mercedes M Monteleone, Hiroto Kambara, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 14, 2006
Cigarette smoke induces proinflammatory cytokine release by activation of NF-kappaB and posttranslational modifications of histone deacetylase in macrophagesSe-Ran Yang, Asiya S Chida, Mark R Bauter, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|October 1, 2004
Oxidative stress and cigarette smoke alter chromatin remodeling but differentially regulate NF-kappaB activation and proinflammatory cytokine release in alveolar epithelial cellsFiona M Moodie, John A Marwick, Charlotte S Anderson, et al.
Pageof 4